These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 19125944)

  • 21. Comparison of probiotics and lactulose in the treatment of minimal hepatic encephalopathy in rats.
    Jia L; Zhang MH
    World J Gastroenterol; 2005 Feb; 11(6):908-11. PubMed ID: 15682492
    [TBL] [Abstract][Full Text] [Related]  

  • 22. An open-label randomized controlled trial of lactulose and probiotics in the treatment of minimal hepatic encephalopathy.
    Sharma P; Sharma BC; Puri V; Sarin SK
    Eur J Gastroenterol Hepatol; 2008 Jun; 20(6):506-11. PubMed ID: 18467909
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Clinical efficacy and safety of lactulose for minimal hepatic encephalopathy: a meta-analysis.
    Luo M; Li L; Lu CZ; Cao WK
    Eur J Gastroenterol Hepatol; 2011 Nov; 23(12):1250-7. PubMed ID: 21971378
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Effect of probiotic treatment on cirrhotic patients with minimal hepatic encephalopathy: A meta-analysis.
    Cao Q; Yu CB; Yang SG; Cao HC; Chen P; Deng M; Li LJ
    Hepatobiliary Pancreat Dis Int; 2018 Feb; 17(1):9-16. PubMed ID: 29428113
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Rifaximin vs. lactulose in treatment of minimal hepatic encephalopathy.
    Sidhu SS; Goyal O; Parker RA; Kishore H; Sood A
    Liver Int; 2016 Mar; 36(3):378-85. PubMed ID: 26201713
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Spectral electroencephalogram in liver cirrhosis with minimal hepatic encephalopathy before and after lactulose therapy.
    Singh J; Sharma BC; Maharshi S; Puri V; Srivastava S
    J Gastroenterol Hepatol; 2016 Jun; 31(6):1203-9. PubMed ID: 26716736
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Critical flicker frequency for diagnosis and assessment of recovery from minimal hepatic encephalopathy in patients with cirrhosis.
    Sharma P; Sharma BC; Sarin SK
    Hepatobiliary Pancreat Dis Int; 2010 Feb; 9(1):27-32. PubMed ID: 20133225
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Efficacy of oral L-ornithine-L-aspartate in cirrhotic patients with hyperammonemic hepatic encephalopathy. Results of a randomized, lactulose-controlled study.
    Poo JL; Góngora J; Sánchez-Avila F; Aguilar-Castillo S; García-Ramos G; Fernández-Zertuche M; Rodríguez-Fragoso L; Uribe M
    Ann Hepatol; 2006; 5(4):281-8. PubMed ID: 17151582
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Reversal of Low-Grade Cerebral Edema After Lactulose/Rifaximin Therapy in Patients with Cirrhosis and Minimal Hepatic Encephalopathy.
    Rai R; Ahuja CK; Agrawal S; Kalra N; Duseja A; Khandelwal N; Chawla Y; Dhiman RK
    Clin Transl Gastroenterol; 2015 Sep; 6(9):e111. PubMed ID: 26378384
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Neuropsychological impairment in severe acute viral hepatitis is due to minimal hepatic encephalopathy.
    Sharma P; Sharma BC; Tyagi P; Kumar M; Sarin SK
    Liver Int; 2009 Feb; 29(2):260-4. PubMed ID: 18710429
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Minimal hepatic encephalopathy in children with chronic liver disease: Prevalence, pathogenesis and magnetic resonance-based diagnosis.
    Srivastava A; Chaturvedi S; Gupta RK; Malik R; Mathias A; Jagannathan NR; Jain S; Pandey CM; Yachha SK; Rathore RKS
    J Hepatol; 2017 Mar; 66(3):528-536. PubMed ID: 27815224
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Minimal hepatic encephalopathy.
    Sharma P
    J Assoc Physicians India; 2009 Nov; 57():760-3. PubMed ID: 20329443
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Cerebral blood flow measured by arterial-spin labeling MRI: a useful biomarker for characterization of minimal hepatic encephalopathy in patients with cirrhosis.
    Zheng G; Zhang LJ; Zhong J; Wang Z; Qi R; Shi D; Lu GM
    Eur J Radiol; 2013 Nov; 82(11):1981-8. PubMed ID: 23849331
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Quality of life in patients with minimal hepatic encephalopathy.
    Ridola L; Nardelli S; Gioia S; Riggio O
    World J Gastroenterol; 2018 Dec; 24(48):5446-5453. PubMed ID: 30622374
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The Effects of Probiotics and Symbiotics on Risk Factors for Hepatic Encephalopathy: A Systematic Review.
    Viramontes Hörner D; Avery A; Stow R
    J Clin Gastroenterol; 2017 Apr; 51(4):312-323. PubMed ID: 28059938
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Non-absorbable disaccharides versus placebo/no intervention and lactulose versus lactitol for the prevention and treatment of hepatic encephalopathy in people with cirrhosis.
    Gluud LL; Vilstrup H; Morgan MY
    Cochrane Database Syst Rev; 2016 May; 2016(5):CD003044. PubMed ID: 27153247
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Treatment with a potassium-iron-phosphate-citrate complex improves PSE scores and quality of life in patients with minimal hepatic encephalopathy: a multicenter, randomized, placebo-controlled, double-blind clinical trial.
    Burkard T; Biedermann A; Herold C; Dietlein M; Rauch M; Diefenbach M
    Eur J Gastroenterol Hepatol; 2013 Mar; 25(3):352-8. PubMed ID: 23117470
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Non-absorbable disaccharides versus placebo/no intervention and lactulose versus lactitol for the prevention and treatment of hepatic encephalopathy in people with cirrhosis.
    Gluud LL; Vilstrup H; Morgan MY
    Cochrane Database Syst Rev; 2016 Apr; 4():CD003044. PubMed ID: 27089005
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Reduction of manganese intake improves neuropsychological manifestations in rats with minimal hepatic encephalopathy.
    Li Y; Mei LH; Qiang JW; Ji CX; Ju S
    Neuroscience; 2017 Apr; 347():148-155. PubMed ID: 28193543
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Clinical efficacy of L-ornithine-L-aspartate in the management of hepatic encephalopathy.
    Kircheis G; Wettstein M; Dahl Sv; Häussinger D
    Metab Brain Dis; 2002 Dec; 17(4):453-62. PubMed ID: 12602521
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.